Evidence map›Paper›PMID 33166290›Full record

ArticlePLoS computational biology2020

Cancer classification based on chromatin accessibility profiles with deep adversarial learning model.

Hai Yang, Qiang Wei, Dongdong Li, Zhe Wang

Abstract read
In one paragraph

Article in PLoS computational biology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Machine Learning in Epigenomics: Insights into Cancer Biology and Medicine.Biochimica et biophysica acta. Reviews on cancer · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Hai YangDepartment of Computer Science and Engineering, East China University of Science and Technology, Shanghai, PR China.ORCID 0000-0002-1161-4337
Qiang WeiDepartment of Molecular Physiology & Biophysics, Vanderbilt University, Nashville, Tennessee, United States of America.ORCID 0000-0001-9926-1646
Dongdong LiDepartment of Computer Science and Engineering, East China University of Science and Technology, Shanghai, PR China.
Zhe WangDepartment of Computer Science and Engineering, East China University of Science and Technology, Shanghai, PR China.ORCID 0000-0002-3759-2041

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Given the complexity and diversity of the cancer genomics profiles, it is challenging to identify distinct clusters from different cancer types. Numerous analyses have been conducted for this propose. Still, the methods they used always do not directly support the high-dimensional omics data across the whole genome (Such as ATAC-seq profiles). In this study, based on the deep adversarial learning, we present an end-to-end approach ClusterATAC to leverage high-dimensional features and explore the classification results. On the ATAC-seq dataset and RNA-seq dataset, ClusterATAC has achieved excellent performance. Since ATAC-seq data plays a crucial role in the study of the effects of non-coding regions on the molecular classification of cancers, we explore the clustering solution obtained by ClusterATAC on the pan-cancer ATAC dataset. In this solution, more than 70% of the clustering are single-tumor-type-dominant, and the vast majority of the remaining clusters are associated with similar tumor types. We explore the representative non-coding loci and their linked genes of each cluster and verify some results by the literature search. These results suggest that a large number of non-coding loci affect the development and progression of cancer through its linked genes, which can potentially advance cancer diagnosis and therapy.

Indexed as

Deep LearningChromatinChromatin Immunoprecipitation SequencingComputational BiologyDatabases, Nucleic AcidGenomicsHumansMultigene FamilyNeoplasmsNormal DistributionOncogenesRNA-SeqChromatin

Identifiers

PMID33166290
PMCPMC7676699

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.